Characterization of a novel class A carbapenemase PAD-1 from Paramesorhizobium desertii A-3-ET, a strain highly resistant to β-lactam antibiotics
Abstract Although clinical antibiotic-resistant bacteria have attracted tremendous attention in the microbiology community, the resistant bacteria that persist in natural environments have been overlooked for a longtime. We previously proposed a new species Paramesorhizobium desertii, isolated from...
Main Authors: | Ruichen Lv, Jingyu Guo, YanFeng Yan, Rong Chen, Lisheng Xiao, Min Wang, Nan Fang, Chengxiang Fang, Yujun Cui, Ruifu Yang, Yajun Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-07841-1 |
Similar Items
-
New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams
by: Juan C. Vázquez-Ucha, et al.
Published: (2020-12-01) -
β-Lactam Antibiotics Renaissance
by: Wenling Qin, et al.
Published: (2014-05-01) -
Imide and isatin derivatives as γ-lactam mimics of ß-lactam antibiotics
by: Peter S. Hadfield, et al.
Published: (2002-08-01) -
Extended Spectrum- and Carbapenemase-Based β-Lactam Resistance in the Arabian Peninsula—A Descriptive Review of Recent Years
by: John Philip Hays, et al.
Published: (2022-10-01) -
Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
by: Yanfang Feng, et al.
Published: (2021-11-01)